The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...

The 15 drugs accounted for $27bn in spending via Medicare Part B and Part D between November 2024 and October 2025.

The Centers for Medicare and Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of ...

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for ...